Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Cardiotoxicity|Toxicity Due to Chemotherapy|Breast Cancer|Lymphoma|Cardiomyopathies|Heart Failure
Interventions: OTHER: Biomarker Guided Intervention
Sponsor: Abramson Cancer Center at Penn Medicine
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)